Case of Anthracycline-induced Cardiogenic Shock: A Call to Optimize Modifiable Cardiac Risk Factors Prior to Chemotherapy

Anthracyclines, including doxorubicin, are an important class of chemotherapeutic agents. Their efficacy, however, is limited by cardiotoxicity. Risk factors for anthracycline-associated cardiotoxicity include dose, treatment-specific risk factors including adjunctive radiotherapy, patient-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabriel, Andre, Stringer, Bryan, Hadfield, Matthew J, Madady, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726340/
https://www.ncbi.nlm.nih.gov/pubmed/31497415
http://dx.doi.org/10.7759/cureus.4961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726340/
https://www.ncbi.nlm.nih.gov/pubmed/31497415
http://dx.doi.org/10.7759/cureus.4961

Ejemplares similares